Omega-3 Fatty Acid Supplementation for Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Symptom Domains
Abstract
Introduction: Omega-3 polyunsaturated fatty acids (PUFAs), particularly EPA and DHA, have been proposed as a complementary treatment for attention-deficit/hyperactivity disorder (ADHD). However, meta-analyses show mixed results, possibly due to pooling across inattention and hyperactivity domains that may respond differently. Description: Systematic review and meta-analysis of RCTs of omega-3 supplementation (≥8 weeks) in children and adolescents (4–18 years) with ADHD diagnosis or elevated symptoms. Primary outcomes: inattention and hyperactivity/impulsivity separately (teacher or parent ratings). Databases: PubMed, PsycINFO, Cochrane. Subgroup analysis by EPA:DHA ratio and baseline PUFA status. Results: Twenty-six RCTs (n=2,211 participants) were included. Omega-3 significantly reduced inattention (SMD –0.29, 95% CI –0.41 to –0.17, p<0.001) but not hyperactivity/impulsivity (SMD –0.11, –0.23 to 0.01, p=0.07). Formulations with EPA:DHA ratio ≥1.5:1 improved inattention more (SMD –0.38) than lower ratios (–0.18). Baseline low PUFA status predicted larger effect (SMD –0.44 vs. –0.16 in normal status). No significant adverse events except mild gastrointestinal symptoms (10% vs. 6% placebo). Discussion: Omega-3 supplementation modestly improves inattention but not hyperactivity in ADHD. Domain-specific effects suggest distinct neurobiological mechanisms: PUFAs may enhance prefrontal dopamine tone (inattention) less than striatal circuits (hyperactivity). The EPA-predominant…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 2,211 participants or records.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.